JPM

210.69

+1.47%↑

BRKB

459.37

+0.54%↑

285.14

-1.17%↓

493.39

-0.33%↓

BAC

+3.4%↑

JPM

210.69

+1.47%↑

BRKB

459.37

+0.54%↑

285.14

-1.17%↓

493.39

-0.33%↓

BAC

+3.4%↑

JPM

210.69

+1.47%↑

BRKB

459.37

+0.54%↑

285.14

-1.17%↓

493.39

-0.33%↓

BAC

+3.4%↑

JPM

210.69

+1.47%↑

BRKB

459.37

+0.54%↑

285.14

-1.17%↓

493.39

-0.33%↓

BAC

+3.4%↑

JPM

210.69

+1.47%↑

BRKB

459.37

+0.54%↑

285.14

-1.17%↓

493.39

-0.33%↓

BAC

+3.4%↑

Home・Aktien・BioNano Genomics Inc

BioNano Genomics Inc

Geschlossen

0.42 5

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.4

Max

0.43

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+675 upside

BioNano Genomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Sept. 2024, 23:50 UTC

Heiße Aktien

Stocks to Watch: Nike, FedEx, Alliance Entertainment Holding, Arq

19. Sept. 2024, 20:59 UTC

Ergebnisse

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q -- Update

19. Sept. 2024, 20:41 UTC

Top News

Nike CEO John Donahoe to Retire

19. Sept. 2024, 20:40 UTC

Ergebnisse

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q

19. Sept. 2024, 23:24 UTC

Market Talk

Sims U.S. Business Shines, But Asia Headwinds Remain -- Market Talk

19. Sept. 2024, 23:01 UTC

Top News

U.K. Consumers Turn Notably Gloomier, Survey Says

19. Sept. 2024, 22:21 UTC

Market Talk

Ergebnisse

FedEx Warns of Continued, Worsening Headwinds in 2Q -- Market Talk

19. Sept. 2024, 22:17 UTC

Top News

Why Fed Rate Cuts Are Hurting Treasury Bonds -- Barrons.com

19. Sept. 2024, 22:13 UTC

Market Talk

Ergebnisse

FedEx Counts on Price Hikes to Help Hurting Top and Bottom Lines -- Market Talk

19. Sept. 2024, 22:13 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

19. Sept. 2024, 22:06 UTC

Ergebnisse

FedEx Stock Is Down. Earnings Show Why The Fed Cut Rates. -- Barrons.com

19. Sept. 2024, 21:46 UTC

Top News

Ergebnisse

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue -- Update

19. Sept. 2024, 21:06 UTC

Ergebnisse

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19. Sept. 2024, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

19. Sept. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. Sept. 2024, 20:50 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

19. Sept. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. Sept. 2024, 20:42 UTC

Ergebnisse

FedEx Stock Skids, Set To Snap Support As Q1 Results Disappoint -- IBD

19. Sept. 2024, 20:39 UTC

Top News

Dow, S&P 500 Hit Records After Rate Cut -- WSJ

19. Sept. 2024, 20:12 UTC

Ergebnisse

FedEx Unable to Provide FY25 EPS or Effective Tax Rate Outlook on GAAP Basis >FDX

19. Sept. 2024, 20:12 UTC

Ergebnisse

FedEx Cash On-Hand as of Aug 31 Was $5.9 B >FDX

19. Sept. 2024, 20:11 UTC

Ergebnisse

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19. Sept. 2024, 20:11 UTC

Ergebnisse

FedEx: 'Committed to Our Plan to Return $3.8 B to Stockholders This Fiscal Yr' >FDX

19. Sept. 2024, 20:11 UTC

Ergebnisse

FedEx Expects Recent Pricing Actions to Help Offset Weaker-Than-Expected Demand Trends >FDX

19. Sept. 2024, 20:10 UTC

Top News

Dow Crosses 42000, Hits Record in Post-Fed Rally -- WSJ

19. Sept. 2024, 20:10 UTC

Ergebnisse

FedEx Reaffirms FY25 Capital Spending of $5.2 B >FDX

19. Sept. 2024, 20:10 UTC

Ergebnisse

FedEx Reaffirms Permanent Cost Reductions From DRIVE Transformation Program of $2.2 B >FDX

19. Sept. 2024, 20:10 UTC

Ergebnisse

FedEx Had Previously Forecast of Low-To-Mid Single Digit Percentage Increase in Rev for FY25>FDX

19. Sept. 2024, 20:09 UTC

Ergebnisse

FedEx Sees Low Single-Digit Percentage Rev Growth Rate Yr Over Yr for FY25>FDX

19. Sept. 2024, 20:09 UTC

Ergebnisse

FedEx Sees FY25 EPS $20 to $21 After Also Excluding Costs Related to Business Optimization Initiatives >FDX

Peer-Vergleich

Kursveränderung

BioNano Genomics Inc Prognose

Kursziel

By TipRanks

675% Vorteil

12-Monats-Prognose

Durchschnitt 3.1 USD 675%

Hoch 5.2 USD

Tief 1 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für BioNano Genomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für BioNano Genomics Inc – Dist abgegeben haben.

Andere Aktien aus dem Sektor

JPM

JP Morgan Chase and Co.

210.69

↑ +1.47%

BRKB

Berkshire Hathaway Inc (Class B)

459.37

↑ +0.54%

Visa Inc. (class A)

285.14

↓-1.17%

Mastercard Inc

493.39

↓-0.33%

BAC

Bank of America Corp.

↑ +3.4%

BioNano Genomics Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

BioNano Genomics Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

BioNano Genomics Inc Prognose

Kursziel

Rating-Konsens

Andere Aktien aus dem Sektor